Foreword
Nature Reviews Cancer 8, 577 (August 2008) | doi:10.1038/nrc2461
Focus on: Targeting Angiogenesis
Limiting supply
Top of page
Abstract
The use of agents that modulate tumour angiogenesis has led to improvements in patient care, and tumour angiogenesis remains an important area for cancer research. As more anti-angiogenic agents proceed through clinical development, it is important to consider what we now know about the effects these agents have on the tumour vasculature and what aspects of tumour angiogenesis remain to be elucidated.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Targeted therapies Goldie?Coldman and bevacizumab beyond disease progressionNature Reviews Clinical Oncology News and Views (01 Jun 2009)
